3
Registered trials
3
Recruiting
2
Unique sponsors
1
Unique IMPs
2
Commercial trials
Drug classes (ATC)
—
ATC code not specified
3
Mechanism of action (INN-stem analysis)
Monoclonal antibody
1 substance
Phase II:
1
Phase I (Other):
2
Phase II
1 trial-
RecruitingNational And Kapodistrian University Of Athens AcademicANIFROLUMAB
Phase I (Other)
2 trials-
RecruitingChugai Pharmaceutical Co. Ltd. CommercialIMP not specified
-
RecruitingChugai Pharmaceutical Co. Ltd. CommercialIMP not specified
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Chugai Pharmaceutical Co. Ltd. | Commercial | 2 | Phase I (Other) | 2 |
| National And Kapodistrian University Of Athens | Academic | 1 | Phase II | 1 |
New trials by year
2024
1
2025
1
2026
1